drugset / Trial / NCT01758406

Transplantation of Autologous Cardiac Stem Cells in Ischemic Heart Failure

NCT01758406 ↗

Phase 2 Unknown 50 enrolled Royan Institute
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is a prospective, randomized, double blind , controlled trial to assess the efficacy of intracoronary transplantation of autologous cardiac stem cells in 50 patients with ischemic heart failure.

Timeline

Start
2013-12
Primary completion
2017-11
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject autologous cardiac stem cells Cell therapy 5e+06 cells Other
Subject autologous cardiac stem cells Cell therapy 1e+07 cells Other

Indications